The global postpartum depression management market is poised to register a 3.8% CAGR, capturing a revenue share of USD 115.1 million in 2022, to reach USD 173.9 million by 2032.
In pregnancy and childbirth, there is an acute case of clinical depression that is called postpartum depression. It is a very common mood disorder examined specifically in pregnant mothers, though it affects both men and women.
As per a study published in a peer-reviewed journal, 1 out of 7 women who gave birth to a newborn suffered from postpartum depression. After three weeks of giving birth to a newborn, a mother starts feeling the effects of depression.
Postpartum depression management market growth is attributed to various factors that affect postpartum depression rates after pregnancy. These risk factors include hormonal and physical changes, a history of depression and stress, emotional imbalance, and bipolar disorder.
In pregnancy, mental disorders and mood swings are driving growth in the postpartum depression management market. Some of the major symptoms of postpartum depression among women include hopelessness, sadness, learning and memorizing, inability to focus, anxiety and exhaustion, loss of interest in self-care, and appetite problems.
| Report Attribute | Details |
|---|---|
| Postpartum Depression Management Market Value (2022) | USD 115.1 Million |
| Postpartum Depression Management Market Anticipated Forecast Value (2032) | USD 173.9 Million |
| Postpartum Depression Management Market Projected Growth Rate (2022 to 2032) | 3.8% |
To achieve better results, getting diagnosed by a doctor is crucial. Antidepressant prescriptions include Bupropion, Amitriptyline, Trimipramine, Fluoxetine, Paroxetine, Fluoxetine, Fluoxetine, Fluoxetine, Fluoxetine, and others. In contrast, counseling involves talk therapy with therapists or psychologists who provide management tips to help combat the conditions.
The growing demand for antidepressant drugs and talk therapies by expectant pregnant mothers is projecting the growth of the postpartum depression management market. Therefore, spending on postpartum depression management is increasing over time.
The postpartum depression management market is growing worldwide as women across the globe are lately experiencing postpartum depression as they find it difficult to cope with new responsibilities. The postpartum depression management market includes various home remedies that involve maintaining healthy lifestyle choices, avoiding isolation, to set realistic expectations.
Based on treatment type, anti-depressants are the most commonly used treatment methods over therapies as anti-depressants provide fast treatment and promising results in less time as compared with psychotherapies.
The anti-depressants treatment segment thus accounts for the largest revenue share in the postpartum depression management market. The segment is anticipated to follow the same trend in the postpartum depression management market over the next few years. As a result, women prefer it over psychotherapies to achieve faster results.
Some of the key factors driving the growth of the postpartum depression management market include the rise in risk factors associated with postpartum depression. These include the growing preference of women for the treatment of postpartum depression.
Women have become more aware of postpartum depression management and are more inclined to seek early treatment and therapies, which is further driving the global market for postpartum depression management.
It is expected that postpartum depression management market growth will be constrained by negligence and unacceptance of the condition, along with an inability to detect depression.
The demand for postpartum depression management has increased in the North American region. North America is anticipated to control a postpartum depression management market share of 37.5% in 2022.
In the last decade, North America has held the largest revenue share in the global postpartum depression management market on account of rising awareness among women regarding postpartum depression. It also enhanced decision-making by women with high educational attainment and easy availability of psychotherapy sessions with specialized doctors.
Europe's Postpartum Depression Management is predicted to experience significant growth and hold a market share of 29% in 2022. Mental health awareness is increasing among individuals and major companies are investing in countries in this region, which is driving revenues in the Europe postpartum depression market.
The market for postpartum depression in Europe is expected to be driven by an increasing number of initiatives to treat postpartum depression through telemedicine virtual support over calls and online counseling, as well as an increasing number of support groups and mental health communities for mothers.
The start-up ecosystem in the postpartum depression management market is clouded by several pharmaceutical companies, including Marinus Pharma and others, who are actively developing therapies to grow the postpartum depression management market share. In addition, they manufacture novel therapies to transform the treatment paradigm of the postpartum depression management market.
Sage Therapeutics and Marinus Pharmaceuticals are two major players developing therapies for postpartum depression (PPD). There will be a significant impact on the postpartum depression (PPD) market from the launch of new therapies such as SAGE-217 and Ganaxolone.
The postpartum depression management market is consolidated with a presence of a few strong players from around the globe. Some of the key players present in the global postpartum depression management market are Sage Therapeutics Inc., Cipla Limited, Sun Pharmaceutical Industries Ltd., Anikem Laboratories, Intas Pharmaceuticals Ltd., Mylan N.V., Sumika Fine Chemicals Co Ltd., and others.
emerging trends in the postpartum depression management market are brought about as a result of the major players' adoption of several growth strategies, including product launches, acquisitions, and collaborations.
Some of the recent developments in the Postpartum Depression Management market are as follows:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.8% from 2022 to 2032 |
| Base Year for Estimation | 2022 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered | Treatment Type, Distribution Channel, Region |
| Regions Covered | North America; Latin America; Western Europe; Eastern Europe; The Asia Pacific excluding Japan; Japan; The Middle East and Africa |
| Key Countries Profiled | The USA, Canada, Brazil, Argentina, Germany, The UK, France, Spain, Italy, Nordics, BENELUX, Australia & New Zealand, China, India, GCC Countries, South Africa |
| Key Companies Profiled | Sage Therapeutics Inc.; Cipla Limited; Sun Pharmaceutical Industries Ltd.; Anikem Laboratories; Intas Pharmaceuticals Ltd.; Mylan N.V.; Sumika Fine Chemicals Co Ltd. |
| Customization | Available Upon Request |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 3: Global Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 4: North America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 5: North America Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 6: North America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 8: Latin America Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 9: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 10: Europe Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 11: Europe Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 12: Europe Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 13: Asia Pacific Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 14: Asia Pacific Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 15: Asia Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Table 16: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2017 to 2032
Table 17: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2017 to 2032
Table 18: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2017 to 2032
Figure 1: Global Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 2: Global Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 3: Global Market Value (US$ Million) by Region, 2022 to 2032
Figure 4: Global Market Value (US$ Million) Analysis by Region, 2017 to 2032
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 7: Global Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 10: Global Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 13: Global Market Attractiveness by Treatment, 2022 to 2032
Figure 14: Global Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 15: Global Market Attractiveness by Region, 2022 to 2032
Figure 16: North America Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 17: North America Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 18: North America Market Value (US$ Million) by Country, 2022 to 2032
Figure 19: North America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 22: North America Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 25: North America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 28: North America Market Attractiveness by Treatment, 2022 to 2032
Figure 29: North America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 30: North America Market Attractiveness by Country, 2022 to 2032
Figure 31: Latin America Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 32: Latin America Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 33: Latin America Market Value (US$ Million) by Country, 2022 to 2032
Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 37: Latin America Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 40: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 43: Latin America Market Attractiveness by Treatment, 2022 to 2032
Figure 44: Latin America Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 45: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 46: Europe Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 47: Europe Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 48: Europe Market Value (US$ Million) by Country, 2022 to 2032
Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 52: Europe Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 55: Europe Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 58: Europe Market Attractiveness by Treatment, 2022 to 2032
Figure 59: Europe Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 60: Europe Market Attractiveness by Country, 2022 to 2032
Figure 61: Asia Pacific Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 62: Asia Pacific Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 63: Asia Pacific Market Value (US$ Million) by Country, 2022 to 2032
Figure 64: Asia Pacific Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 67: Asia Pacific Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 70: Asia Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 73: Asia Pacific Market Attractiveness by Treatment, 2022 to 2032
Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 75: Asia Pacific Market Attractiveness by Country, 2022 to 2032
Figure 76: Middle East and Africa Market Value (US$ Million) by Treatment, 2022 to 2032
Figure 77: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2022 to 2032
Figure 78: Middle East and Africa Market Value (US$ Million) by Country, 2022 to 2032
Figure 79: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2017 to 2032
Figure 80: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 81: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 82: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2017 to 2032
Figure 83: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2022 to 2032
Figure 84: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2022 to 2032
Figure 85: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2017 to 2032
Figure 86: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2022 to 2032
Figure 87: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2022 to 2032
Figure 88: Middle East and Africa Market Attractiveness by Treatment, 2022 to 2032
Figure 89: Middle East and Africa Market Attractiveness by Distribution Channel, 2022 to 2032
Figure 90: Middle East and Africa Market Attractiveness by Country, 2022 to 2032
The postpartum depression management market is likely to account for USD 173.9 million by 2032.
North America is likely to hold a postpartum depression management market share of 37.5% in 2022.
The global postpartum depression management market is set to advance at a CAGR of 3.8% from 2022 to 2032.
The postpartum depression management market is projected to grow to USD 115.1 million in 2022.
Explore Similar Insights
Postpartum Depression Management Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
